Czechia vs Iceland: Breast cancer screening coverage in Europe
Czechia
60.0%
in 2022
Iceland
54.0%
in 2021
Czechia rank
10th
Iceland rank
13th
Breast cancer screening coverage in Europe over time
- Czechia
- Iceland
How they compare
Czechia currently reports 60.0% against 54.0% in Iceland, a difference of 6.0%.
That makes Czechia's figure about 1.1 times Iceland's.
The two have swapped places 3 times across 18 shared years of data; in 2004 it was Iceland ahead.
Czechia ranks 10th and Iceland ranks 13th of 26 countries.
Across the 3 decades both report, Czechia averaged higher in 1 and Iceland in 2.
Head to head by decade
| Decade | Czechia | Iceland | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 38.9% | 61.5% | 22.6% | Iceland |
| 2010s | 57.6% | 58.2% | 0.6% | Iceland |
| 2020s | 58.8% | 58.0% | 0.8% | Czechia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher breast cancer screening coverage in europe, Czechia or Iceland?
- Czechia, at 60.0% against 54.0% in Iceland as of 2022.
- What is the difference in breast cancer screening coverage in europe between Czechia and Iceland?
- 6.0%, with Czechia ahead.
- How many years of comparable data are there for Czechia and Iceland?
- 18 years are reported by both, from 2004 to 2021.
- How do Czechia and Iceland rank globally for breast cancer screening coverage in europe?
- Czechia ranks 10th and Iceland ranks 13th of 26 countries.
- Where does this data come from?
- Eurostat (2024) – processed by Our World in Data, published as Breast cancer screening coverage in Europe. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Share of women aged 50 to 69 years who have been screened for breast cancer within the previous 2 years.